For women with existing thyroid conditions, such as hypothyroidism managed with levothyroxine, GLP-1 medications dont directly interact with thyroid hormone replacement
I would recommend this product to those who struggle with overeating and need help managing their appetite, but it's essential to be aware of the potential side effects and to monitor your body's responses closely
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
Generic and biosimilar timeline The pharmaceutical patent landscape suggests that generic and biosimilar versions of current GLP-1 medications will eventually enter the market, though not immediately